Cloning of a gene fragment encoding chicken complement component C3d with expression and immunogenicity of Newcastle disease virus F gene-C3d fusion protein

Avian Pathology

Volumn 37, Issue 5, 2008, Pages 477-485

  Liu, Dong ^a,b   Niu, Zhong Xiang ^a  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

^b Jinan Animal Husbandry and Veterinary Bureau   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; HYBRID PROTEIN; VIRUS DNA; VIRUS FUSION PROTEIN; VIRUS VACCINE;

ANIMAL; ARTICLE; BIRD DISEASE; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; NEWCASTLE DISEASE PARAMYXOVIRUS; PHYSIOLOGY; PLASMID; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; CHICKENS; CLONING, MOLECULAR; COMPLEMENT C3; DNA, VIRAL; GENE EXPRESSION REGULATION; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; PLASMIDS; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL FUSION PROTEINS; VIRAL VACCINES;

BOS; ESCHERICHIA COLI; GALLUS GALLUS; MUS; NEWCASTLE DISEASE VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 51849114338     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079450802356920     Document Type: Article

References (27)

1. Carter, R.H., Spycher, M.O., Ng, Y.C., Hoffman, R. & Fearon, D.T. (1988). Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. Journal of Immunology, 141, 457-463.
2. Carter, R.H. & Fearon, D.T. (1989). Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM. Journal of Immunology, 143, 1755-1760.
3. Dempsey, P.W., Allison, M.E., Akkaraju, S., Goodnow, C.C. & Fearon, D.T. (1996). C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science, 271, 348-350.
4. Donnelly, J.J., Ulmer, J.B. & Liu, M.A. (1998). DNA vaccines. Developments in biological standardization, 95, 43-53.
5. Elke, S.B., Wolfgang, W.L. & George, C.T. (2006). Complement 3d: from molecular adjuvant to target of immune escape mechanisms. Clinical Immunology, 121, 177-185.
6. Firth, M.A., Moore, D.P., Pei, Y.L., Shewen, P.E., Lo, R.Y.C., Yoo, D.W. & Hodgins, D.C. (2006). Cloning of a gene fragment encoding bovine complement component C3d with expression and characterization of derived fusion proteins. Veterinary Immunology and Immunopathology, 114, 61-71.
7. Green, T.D., Newton, B.R., Rota, P.A., Xu, Y., Robinson, H.L. & Ross, T.M. (2001). C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine, 20, 242-248.
8. Green, T.D., Montefiori, D.C. & Ross, T.M. (2003). Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. Journal of Virology, 77, 2046-2055.
9. Griffioen, A.W., Rijkers, G.T., Janssens-Korpela, P. & Zegers, B.J. (1991). Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infection and Immunity, 59, 1839-1845.
10. Haas, K.M., Toapanta, F.R., Oliver, J.A., Poe, J.C., Weis, J.H., Karp, D.R., Bower, J.F., Ross, T.M. & Tedder, T.F. (2004). Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. Journal of Immunology, 172, 5833-5837.
11. Li, D.J., Wang, H.M., Li, L., Zhao, X.R., Wang, M.Y., Zhu, Y., Meng, Y. & Yuan, M.M. (2003). Gene fusion of molecular adjuvant C3d to hCG( enhances the anti-hCG( antibody response in DNA immunization. Journal of Reproductive Immunology, 60, 129-141.
12. Liu, X.F., Wan, H.Q., Ni, X.X., Wu, Y.T. & Liu, W.B. (2003) Pathotypical and genotypical characterization of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985-2001. Archives of Virology, 148, 1387-1403.
13. Ma, X.Y., Han, J.Q., Gao, S.X. & Niu, Z.X. (2006). Study on isolating complement C3d from the chicken serum by the method of immuno affinity chromatography. Journal of Northwest Sci-Tech University of Agriculture and Forestry, 34, 55-58.
14. Mayo, M.A. (2002). Virus taxonomy. Archives of Virology, 147, 1071-1076.
15. Millar, N.S., Chambers, P. & Emmerson, P.T. (1988). Nucleotide sequence of the fusion and hemaglutinin-neurominidase glycoprotein genes of Newcastle disease virus strain Ulster: molecular basis for variations in pathogenicity between strains. Journal of General Virology, 69, 613-620.
16. Mitchell, J.A., Green, T.D., Bright, R.A. & Ross, T.M. (2003). Induction of heterosubtypic immunity to influenza A virus using a DNAvaccine expressing hemagglutinin-C3d fusion proteins. Vaccine, 21, 902-914.
17. Nagai, Y., Kenk, H.I. & Rott, R. (1976). Proteolytic cleavage of the viral glycoprotein and its significance for the virulence of Newcastle disease virus. Virology, 72, 494-508.
18. Robinson, H.L. (1997). DNA vaccines for immunodeficiency viruses. AIDS, 11(Suppl A), S109-S119.
19. Robinson, H.L. & Pertmer, T.M. (2000). DNA vaccines for viral infections: basic studies and applications. Advances In Virus Research, 55, 1-74.
20. Ross, T.M., Xu, Y., Bright, R.A. & Robinson, H.L. (2000). C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nature Immunology, 1, 127-131.
21. Ross, T.M., Xu, Y., Green, T.D., Montefiori, D.C. & Robinson, H.L. (2001). Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Research and Human Retroviruses, 17, 829-835.
22. Sambrook, J., Fritsch, E.F. & Maniatis, T., (1989). Molecular Cloning - A Laboratory Manual 2nd edn (pp. 24-28). Cold Spring Harbor Laboratory Press, Woodbury, NY, 1989, pp. 24-28.
23. Suradhat, S., Braun, R.P., Lewis, P.J., Babiuk, L.A., van Drunen Littelvan den Hurk, S., Griebel, P.J. & Baca-Estrada, M.E. (2001). Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization. Veterinary Immunology and Immunopathology, 83, 79-92.
24. Test, S.T., Mitsuyoshi, J., Connolly, C.C. & Lucas, A.H. (2001). Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infection and Immunity, 69, 3031-3040.
25. Umino, Y., Kohama, T., Sato, T.A., Sugiura, A., Klenk, H.D. & Rott, R. (1990). Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization with particular reference to the conformational change of envelope glycoprotein associated with proteolytic cleavage. Journal of General Virology, 71, 1189-1197.
26. Wang, L., Sunyer, J.O. & Bello, L.J. (2004). Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea viruses. Journal of Virology, 78, 1616-1622.
27. Watanabe, I., Ross, T.M., Tamura, S., Ichinohe, T., Ito, S., Takahashi, H., Sawa, H., Chiba, J., Kurata, T., Sata, T. & Hasegawa, H. (2003). Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine, 21, 4532-4538.